ICURE's IPO

ICURE raised a round of funding on July 12, 2018. Investors include Public.

ICURE (아이큐어) (KOSDAQ: 175250) is a provider of Transdermal Drug Delivery Systems. The company is focused on the research & development of transdermal drug penetration and diverse patch structu…

Articles about ICURE's IPO: